These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 25920510)

  • 1. The clinical impact of staging bone marrow examination on treatment decisions and prognostic assessment of lymphoma patients.
    Painter D; Smith A; de Tute R; Crouch S; Roman E; Jack A
    Br J Haematol; 2015 Jul; 170(2):175-8. PubMed ID: 25920510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of concordant and discordant bone marrow involvement on outcome in diffuse large B-cell lymphoma treated with R-CHOP.
    Sehn LH; Scott DW; Chhanabhai M; Berry B; Ruskova A; Berkahn L; Connors JM; Gascoyne RD
    J Clin Oncol; 2011 Apr; 29(11):1452-7. PubMed ID: 21383296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of concordant and discordant cytomorphology of bone marrow involvement in patients with diffuse, large, B-cell lymphoma treated with R-CHOP.
    Shim H; Oh JI; Park SH; Jang S; Park CJ; Huh J; Suh C; Chi HS
    J Clin Pathol; 2013 May; 66(5):420-5. PubMed ID: 23610041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can flow cytometry of bone marrow aspirate predict outcome of patients with diffuse large B cell lymphoma? A retrospective single centre study.
    Wolach O; Fraser A; Luchiansky M; Shapiro C; Radnay J; Shpilberg O; Lishner M; Lahav M
    Hematol Oncol; 2015 Mar; 33(1):42-7. PubMed ID: 24470400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow trephine biopsy involvement by lymphoma: review of histopathological features in 511 specimens and correlation with diagnostic biopsy, aspirate and peripheral blood findings.
    Sovani V; Harvey C; Haynes AP; McMillan AK; Clark DM; O'Connor SR
    J Clin Pathol; 2014 May; 67(5):389-95. PubMed ID: 24327662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometry in the bone marrow evaluation of follicular and diffuse large B-cell lymphomas.
    Palacio C; Acebedo G; Navarrete M; Ruiz-Marcellán C; Sanchez C; Blanco A; López A
    Haematologica; 2001 Sep; 86(9):934-40. PubMed ID: 11532621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occult bone marrow involvement in patients with diffuse large B-cell lymphoma: results of a pilot study.
    Talaulikar D; Dahlstrom JE; Shadbolt B; McNiven M; Broomfield A; Pidcock M
    Pathology; 2007 Dec; 39(6):580-5. PubMed ID: 18027262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical significance in detection of immunoglobulin heavy chain clonal rearrangement in bone marrow of patients with B cell lymphoma].
    Chen ZY; Zhou XY; Zhang TM; Hong XN; Yin JL; Hu XC; Shi DR
    Zhonghua Zhong Liu Za Zhi; 2009 Mar; 31(3):183-8. PubMed ID: 19615255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cytogenetic and clinical study on 126 cases of B cell non-Hodgkin's lymphoma with bone marrow involvement].
    An G; Zhang JW; Shi LH; Yi SH; Zhao YZ; Qi JY; Zou DH; Qiu LG
    Zhonghua Xue Ye Xue Za Zhi; 2011 Jan; 32(1):34-7. PubMed ID: 21429399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical role of flow cytometry in redefining bone marrow involvement in diffuse large B-cell lymphoma (DLBCL) - a new perspective.
    Talaulikar D; Shadbolt B; Bell J; Khan K; Dahlstrom JE; McDonald A; Pidcock M; Broomfield A
    Histopathology; 2008 Feb; 52(3):340-7. PubMed ID: 18269585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential prognostic implications of whole-body bone marrow MRI in diffuse large B-cell lymphoma patients with a negative blind bone marrow biopsy.
    Adams HJ; Kwee TC; Lokhorst HM; Westerweel PE; Fijnheer R; Kersten MJ; Verkooijen HM; Stoker J; Nievelstein RA
    J Magn Reson Imaging; 2014 Jun; 39(6):1394-400. PubMed ID: 24310955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of molecular staging by PCR-amplification of immunoglobulin gene rearrangements in diffuse large B-cell lymphoma (DLBCL).
    Mitterbauer-Hohendanner G; Mannhalter C; Winkler K; Mitterbauer M; Skrabs C; Chott A; Simonitsch-Klupp I; Gleiss A; Lechner K; Jaeger U
    Leukemia; 2004 Jun; 18(6):1102-7. PubMed ID: 15085149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The value of combined use of bone marrow smear and section in lymphoma for diagnosis and staging].
    Cui P; Lou F; Fu Y
    Zhonghua Nei Ke Za Zhi; 1999 Jul; 38(7):473-5. PubMed ID: 11798685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognostic impact of bone marrow involvement (BMI) and therapies in diffuse large B cell lymphoma].
    Yi SH; Xu Y; Zou DH; An G; Zhao YZ; Qi JY; Qiu LG
    Zhonghua Xue Ye Xue Za Zhi; 2009 May; 30(5):307-12. PubMed ID: 19799125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow examination has limited value in the staging of patients with an anaplastic large cell lymphoma first presenting in the skin. Retrospective analysis of 107 patients.
    Benner MF; Willemze R
    Br J Dermatol; 2008 Nov; 159(5):1148-51. PubMed ID: 18782320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of bone marrow examination in Hodgkin lymphoma: report of three cases with review of literature.
    Kini JR; Suresh PK; Sinha R; Sahu KK; Kumar S; Prasad K
    J Cancer Res Ther; 2012; 8(3):457-9. PubMed ID: 23174737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.
    Rasmussen PK
    Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow involvement in patients with posttransplant lymphoproliferative disorders: incidence and prognostic factors.
    Montanari F; O'Connor OA; Savage DG; Zain JM; Venkatraman S; McCormick EK; Crook MT; Tsao L; Sevilla DW; Bhagat G; Alobeid B
    Hum Pathol; 2010 Aug; 41(8):1150-8. PubMed ID: 20381113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Precision of histological bone marrow staging in follicular lymphoma and diffuse large B-cell lymphoma.
    Chen T; McDonald A; Shadbolt B; Talaulikar D
    Clin Invest Med; 2012 Dec; 35(6):E358-64. PubMed ID: 23217561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of bone marrow examination in 275 patients with histological features that suggest an indolent type of cutaneous B-cell lymphoma.
    Senff NJ; Kluin-Nelemans HC; Willemze R
    Br J Haematol; 2008 Jul; 142(1):52-6. PubMed ID: 18422781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.